@DrPaulyDeSantis @szusmani @SandyWong02111 @myelomatom the trial also tests subcutaneous dosing (don't know if that already started)
https://t.co/TJI3cjyCZC

There is also a combination trial with Daratumumab SC (Pre-treatment with dara was found to enhance Teclistamab efficacy); would be nice if both could be SC 
#Genmab $GMAB $JNJ